2MX-17338-46810
3 vaccinations
4 coded responses
26 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 927 / CA
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2020-12-19
Registered in v-safe
- 2020-12-19
- 2020-12-20
- 2020-12-21
-
2020-12-22
Survey response — days 1–6 daily, dose 1MedDRA: Vertigo — Feeling: Fair · Be unable to do your normal daily activitiesFree text: VertigoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-22
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2020-12-23
- 2020-12-25
- 2021-01-01
-
2021-01-06
Dose 2 — Pfizer-BioNTech
-
2021-01-08
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction — Feeling: Good · Site: Pain · Chills, Muscle or body aches, Fatigue or tirednessFree text: Symptoms noted 1/7MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-09
- 2021-01-15
- 2021-01-23
- 2021-02-03
- 2021-02-10
- 2021-02-19
- 2021-04-09
- 2021-07-09
-
2021-10-01
Dose 3 — Pfizer-BioNTech
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Pain in armpitMedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Pain under armpitMedDRA releases: 2024-11 · check-in free text available
- 2021-10-08
- 2021-10-15
- 2021-10-23
- 2021-11-01
- 2021-11-07
- 2021-11-12
- 2022-01-02
- 2022-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-06 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2020-12-22 | priority 2/3 |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Vertigo
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Symptoms noted 1/7
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Pain in armpit
Systemic reaction (other): Pain under armpit
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Axillary pain | · | · | ✓ |
| SRO | Unevaluable event | ○ | ○ | ○ |
| SRO | Vertigo | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release